Evolving Options for the Treatment of Metastatic Breast Cancer: Progression-Free Survival as an Endpoint

Cancer Treatment Reviews - United Kingdom
doi 10.1016/j.ctrv.2011.01.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Evolving Role of Receptors as Predictive Biomarkers for Metastatic Breast Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2018English

Disease-Free Survival in Patients With Non-Metastatic Breast Cancer

Revista da Associacao Medica Brasileira
Medicine
2016English

Choosing Treatment for Metastatic Breast Cancer.

BMJ
1982English

An Audit Strategy for Progression-Free Survival

Biometrics
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2011English

Vectors for Treatment of Metastatic Breast Cancer

2005English

Precision Health for Breast Cancer Metastasis: Biomaterial Scaffolds as an Engineered Metastatic Niche to Define, Study, and Monitor Metastatic Progression

Oncoscience
Cancer ResearchOncology
2019English

Prolonged Survival of Patients Receiving Trastuzumab Beyond Disease Progression for HER2 Overexpressing Metastatic Breast Cancer (MBC)

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2005English

Metastatic Triple Negative Breast Cancer: Optimizing Treatment Options, New and Emerging Targeted Therapies

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

The Evolving Treatment Options for Diabetic Macular Edema

International Journal of Inflammation
AllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy